National Bank of Canada FI Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

National Bank of Canada FI purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund purchased 511,238 shares of the biopharmaceutical company’s stock, valued at approximately $37,114,000. Several other hedge funds also recently modified their holdings of the company. Morgan Stanley boosted its position in […]

Related Keywords

Canada ,United States ,Bretta Pletcher ,Complera Eviplera ,Morgan Stanley ,National Bank ,Gilead Sciences ,Securities Exchange Commission ,Quarter For Gilead Sciences ,Capital Group ,Thrivent Financial For Lutherans ,Koshinski Asset Management Inc ,Gilead Sciences Inc ,Nasdaq ,Maxim Group ,Gilead Sciences Profile Get Rating ,Get Rating ,Matthew Hamilton ,Asset Management ,Private Capital Group ,Exchange Commission ,Sciences Profile ,Visit Holdingschannel ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,